comparemela.com

Latest Breaking News On - ஆஷ்லே ஹார்டின் - Page 5 : comparemela.com

Cabell sheriff paints picture of opioid crisis through testimony

Cabell County Sheriff Chuck Zerkle CHARLESTON – At the landmark federal opioid trial, Cabell County Sherriff Chuck Zerkle testified being directly involved in Huntington, once deemed “epicenter of the opioid crisis,” has evolved.  During his testimony May 27, Zerkle said he wanted to make a difference and to help combat issues he believes are harming the community. “One of the reasons I ran for sheriff was I felt I could make a difference in our community,” said Zerkle, who has been a Cabell County resident since 1985 working various positions in law enforcement and private industry.  Farrell Cabell County and the City of Huntington sued the three largest pharmaceutical distribution companies –  AmerisourceBergen, Cardinal Health and McKesson Corp. – in 2017 claiming the companies were largely responsible for the opioid crisis after the companies shipped more than 81 million hydrocodone and oxycodone pills to the county of just

Drug companies grill addiction science director about funding numbers, program timelines

CHARLESTON – As the landmark federal opioid trial concluded its fourth week, attorneys for Cardinal Health probed an addiction science professor from Marshall University about recovery programs and estimated costs.  The City of Huntington and the Cabell County Commission sued three of the nation’s top pharmaceutical distribution companies – AmerisourceBergen, Cardinal Health and McKesson – in 2017 seeking compensation over claims the companies helped fuel the opioid epidemic by sending more than 81 million controlled substances to the county between 2006 and 2014.  Before the start of testimony May 28, U.S. District Judge David Faber, who is overseeing the bench trial, brought up previously admitted documents that were not presented to the media. Faber said that while he does worry about how the media can misconstrue the documents, with a previous ruling in mind, he felt the public had the right to see the documents. 

Drug distributors object to expert witness with DEA background looking at company data

CHARLESTON – All three major drug distribution companies objected to Cabell County and Huntington attorneys bringing in an expert witness with a U.S. Drug Enforcement Administration background to examine opioid data.  The City of Huntington and Cabell County sued three of the largest distribution companies – AmerisourceBergen, Cardinal Health and McKesson Corp – in 2017, seeking the parties be held responsible for shipping over 81 million prescription pain pills into the area of 100,000 residents. Five of 77 pharmacies in Cabell County and Huntington, received over 23.2 million pills between 2006 and 2014 according to the data released by DEA.  Attorney Paul Farrell Jr., representing Cabell County, called James Rafalski, a former DEA official to the stand May 26. Rafalski investigated registrants, collect due diligence files and put together reports to determine effective controls to prevent diversion on behalf of the DEA.

McKesson warned customers nearing threshold limits

CHARLESTON – Attorneys representing Cabell County and the City of Huntington probed a McKesson sales representative on warning customers of nearing threshold limits, pushing increases and pushing sales – including controlled substances.  Huntington and Cabell County sued the nation s three largest pharmaceutical distribution companies – AmerisourceBergen, Cardinal Health and McKesson – in 2017 seeking to hold the companies accountable for their alleged part in the opioid epidemic by sending more than 540,000 opioids each month to independent and chain pharmacies – excluding hospitals and/or hospital pharmacies – located in Cabell County. On May 25, defense attorney Eric Kennedy called Timothy Ashworth, regional sales representative with McKesson to the stand. 

Emails show McKesson employees felt overwhelmed, not possible to be truly diligent

CHARLESTON – As the landmark federal opioid trial entered its fourth week, plaintiffs jumped into McKesson Corporation’s threshold guidelines and due diligence process.  During testimony on May 24, McKesson Corp. Director of Regulatory Affairs Michael Oriente testified that the Controlled Substance Monitoring Program was being developed as he transitioned into the DRA position.  Under CSMP, a threshold system was created for all schedule two through five substances. Oriente said customers only were permitted to receive up to the threshold number and then they would be blocked. McKesson had a three-level review process to determine if the order was suspicious.  Faber McKesson distribution centers are sectioned into four districts and have five DRA positions, according to Oriente. 

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.